ondansetron has been researched along with Vasospasm, Intracranial in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Vasospasm, Intracranial: Constriction of arteries in the SKULL due to sudden, sharp, and often persistent smooth muscle contraction in blood vessels. Intracranial vasospasm results in reduced vessel lumen caliber, restricted blood flow to the brain, and BRAIN ISCHEMIA that may lead to hypoxic-ischemic brain injury (HYPOXIA-ISCHEMIA, BRAIN).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Della Faille, L | 1 |
| Claesen, E | 1 |
| Cappelle, S | 1 |
| Lemmens, R | 1 |
1 other study available for ondansetron and Vasospasm, Intracranial
| Article | Year |
|---|---|
Reversible cerebral vasoconstriction syndrome triggered by ondansetron.
Topics: Antiemetics; Female; Humans; Ondansetron; Vasoconstriction; Vasospasm, Intracranial; Young Adult | 2021 |